EXAGEN INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price
EXAGEN INC. (XGN) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price of $7.42 per share as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice · last filed 2026-08-04
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $7.42.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $7.68.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $8.07.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $8.11.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2026-06-30 | $7.42 10-Q · filed 2026-08-04 |
| 2026-03-31 | $7.68 10-Q · filed 2026-05-11 |
| 2025-12-31 | $8.07 10-K · filed 2026-03-10 |
| 2025-09-30 | $8.11 10-Q · filed 2025-11-04 |
| 2025-06-30 | $8.54 10-Q · filed 2025-07-29 |
| 2025-03-31 | $8.60 10-Q · filed 2025-05-05 |
| 2024-12-31 | $8.65 10-K · filed 2025-03-11 |
| 2023-12-31 | $12.46 10-K · filed 2024-03-18 |
| 2022-12-31 | $12.94 10-K · filed 2023-03-20 |
| 2021-12-31 | $10.17 10-K · filed 2022-03-22 |
| 2020-12-31 | $6.75 10-K · filed 2021-03-16 |
| 2020-09-30 | $6.51 10-Q · filed 2020-11-10 |
| 2020-06-30 | $2.42 10-Q · filed 2020-07-28 |
| 2020-03-31 | $3.77 10-Q · filed 2020-05-11 |
| 2019-12-31 | $3.49 10-K · filed 2020-03-25 |
| 2019-09-30 | $30.74 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |